Medicines Formulary

MEDICINES FORMULARY

Updated February 2018

INTRODUCTION

The formulary comprises a list of medicines which have been approved by East Cheshire NHS Trust Medicines Management Group (MMG)for prescribing within the Trust. In order to add a drug to the formulary the consultant will need to complete an application from and submit for consideration at the next MMG.

The purpose of the formulary is to ensure evidence-based and cost-effective prescribing and provide information relating to drug use. All prescribing from within the Trust (i.e. in-patient, out-patient and FP10 prescribing) must comply with the formulary. Advice given to GPs with regard to drug treatment options must also be in line with Trust formulary recommendations. This will be monitored on an on-going basis.

Under the NHS Constitution, patients have the right to drugs and treatments recommended by NICE if their doctor thinks it is clinically appropriate.NICE (National Institute for Health and Clinical Excellence, is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health. NICE guidance is based on the best available evidence of the most effective care, looking at clinical and cost effectiveness, and aims to ensure treatment is available equally across different regions.

East Cheshire NHS Trust has a responsibility to implement NICE guidance to ensure patients receive the best and most appropriate treatment and that NHS resources are not wasted by inappropriate treatment. The Trust has a process in place to enable access to all NICE-approved medicines. The formulary below highlights the drugs available to patients in line with NICE recommendations. Any NICE guidance that is not applicable to the Trust (e.g. we do not provide those services here) are highlighted at the end of the formulary.

If a medicine does not appear on the formulary does not exclude it from being used in the Trust if deemed clinically appropriate. In this case, these drugs may still be available on an individual basis if exceptional circumstances exist.

Formulary is organised in line with BNF chapters

1 / Gastro-intestinal system
2 / Cardiovascular system
3 / Respiratory system
4 / Central nervous system
5 / Infections – SEE ECT ANTIBIOTIC POLICY
6 / Endocrine system
7 / Obstetrics, gynaecology and urinary tract disorders
8 / Malignant disease and immunosuppression
9 / Nutrition and blood
10 / Musculoskeletal and joint diseases
11 / Eye
12 / Ear, nose and oropharynx
13 / Skin
14 / Immunological products and vaccines
15 / Anaesthesia
1 /

Gastro-Intestinal System

PBR

Relevant NICE TA

1.1 Dyspepsia and gastro-oesophogeal reflux-disease

1.1.1 Antacids and simeticone

MAGNESIUM TRISILICATE MIXTURE
ASILONE LIQUID
SODIUM CITRATE SOLUTION

1.1.2 Compound alginates and proprietary indigestion preparations

GAVISCON ADVANCE SF SUSPENSION
GAVISCON INFANT DUAL-SACHETS

1.2 Antispasmodics and other drugs altering gut motility

HYOSCINE BUTYLBROMIDE INJECTION and TABLETS (first line)
MEBEVERINE 135mg TABLETS (first line)
PEPPERMIINT OIL E/C CAPSULES (Mintec)
ALVERINE CITRATE CAPSULES
MEBEVERINE 50mg/5ml LIQUID

1.3.1 H2 receptor antagonists

RANITIDINE INJECTION LIQUID and TABLETS
RANITIDINE 150mg EFFERVESCENT TABLETS (note high sodium content)

1.3.3

Chelates and complexes

1.3.4

Prostaglandin analogues

MISOPROSTOL 200microgram TABLETS

1.3.5

Proton pump inhibitors

LANSOPRAZOLE CAPSULES
OMEPRAZOLE CAPSULES AND INJECTION
PANTOPRAZOLE TABLETS
ESOMEPRAZOLE CAPSULES – Restricted use severe GORD
LANSOPRAZOLE ORODISPERSIBLE TABLETS – 1st line for patients with swallowing difficulties only
OMEPRAZOLE DISPERSIBLE TABLETS (MUPS) – 2nd line for patients with swallowing difficulties only

1.4.2

Antimotility drugs

LOPERAMIDE CAPSULES and LIQUID
LOPERAMIDE DISPERSIBLE TABLETS – use as a 3rd line option in pts with a high stoma outputonly
ELUXADOLINE 100mg CAPSULES / NICE TA 471

1.5

Chronic bowel disorder

1.5.1

Aminosalicylates

BALSALAZIDE 750mg CAPSULES
MESALAZINE 1g FOAM ENEMA ( Asacol or Salofalk)
MESALAZINE 1g M/R SACHETS (Pentasa)
MESALAZINE 1g SUPPOSITORIES
MESALAZINE 250mg SUPPOSITORIES
MESALAZINE 500mg SUPPOSITORIES
MESALAZINE M/R TABLETS (Asacol MR)
MESALAZINE E/C TABLETS (Octasa MR)
MESALAZINE 500mg M/R TABLETS (Pentasa)
MESALAZINE 250mg E/C TABLETS (Salofalk)
SULFASALAZINE TABLETS
MESALAZINE 1200mg M/R TABLETS (Mezavant)

1.5.2

Corticosteroids

HYDROCORTISONE 10% FOAM (COLIFOAM) (1ST LINE)
PREDNISOLONE 20mg in 100ml ENEMA
BUDESONIDE 3mg M/R CAPSULES (Entocort)

1.5.3

Drugs affecting immune response

AZATHIOPRINETABLETS

CICLOSPORIN CAPSULES

CICLOSPORIN INJECTION

MERCAPTOPURINE TABLETS

METHOTREXATE INJECTION – available as Homecare

METHOTREXATE 2.5mg TABLETS – Administered as WEEKLY dose,

VEDOLIZUMAB

TA342, TA 325 Treating moderately to severely active UC

USTEKINUMAB

TA456

Cytokine modulators

See section 10.1.3

Yes

1.6

Laxatives

1.6.1

Bulk-forming laxatives

ISPAGHULA HUSK SACHETS (Fybogel orange)
NORMACOL SACHETS

1.6.2

Stimulant laxatives

BISACODYL SUPPOSITORIES and TABLETS
DOCUSATE SODIUM CAPSULES and LIQUID
GLYCEROL SUPPOSITORIES
SENNA LIQUID and TABLETS
CO-DANTHRAMER CAPSULES and LIQUID – Only for constipation in terminally ill patients of all ages
CO-DANTHRUSATE CAPSULES and LIQUID - Only for constipation in terminally ill patients of all ages

1.6.3

Faecal softeners

1.6.4

Osmotic laxatives

MACROGOL 3350 SACHETS (Movicol)
MICOLETTE/RELAXIT MICRO-ENEMA
MOVICOL PAEDIATRIC SACHETS
LACTULOSE SOLUTION
PHOSPHATE ENEMA (133ml)

1.6.5

Bowel cleansing preparations

KLEAN-PREP SACHETS
PICOLAX SACHETS
MOVIPREP SACHETS
CITRAFLEET SACHETS

1.6.7

5HT4 receptor agonists

PRUCALOPRIDE 2mg TABLETS / TA211 Prucalopride for the treatment of chronic constipation in women
LINACLOTIDE 290 MICROGRAMS
LUBIPROSTONE 24mcg capsules / TA318 Lubiprostone for treating chronic idiopathic constipation
1.6.8 / Mu-opiod receptor antagonist
Naloxegol / TA 345 Naloxegol for treating opioid-induced constipation

1.7

Local preparations for anal and rectal disorders

1.7.1

Soothing haemorrhoidal preparations

ANUSOL OINTMENT
ANODESYN SUPPOSITORIES

1.7.2

Compound haemorrhoidal preparations with corticosteroids

ANUSOL-HC OINTMENT
SCHERIPROCT OINTMENT

1.7.3

Rectal sclerosants

PHENOL 5% INJECTION OILY
GLYCERYL TRINITRATE 0.4% RECTAL OINTMENT

1.8

Stoma care

1.9

Drugs affecting intestinal secretions

1.9.1

Drugs affecting biliary composition and flow

URSODEOXYCHOLIC ACID CAPSULES LIQUID and TABLETS

1.9.4

Pancreatin

CREON 10,000 CAPSULES
CREON 25,000 CAPSULES
CREON 40,000 CAPSULES
2 /

Cardiovascular system

PBR

Relevant NICE TA

2.1

Positive inotropic drugs

2.1.1

Cardiac glycosides

DIGOXIN INJECTION, LIQUID and TABLETS
DIGIFAB INJECTION

2.1.2

Phosphodiesterase type-3 inhibitors

ENOXIMONE INJECTION
MILRINONE INJECTION

2.2.1

Thiazides and related diuretics

INDAPAMIDE 2.5mg TABLETS
CHLORTALIDONE 50mg TABLETS
CHLOROTHIAZIDE - paeds only
BENDROFLUMETHIAZIDE 2.5mg TABLETS
INDAPAMIDE 1.5mg M/R TABLETS

2.2.2

Loop diuretics

BUMETANIDE LIQUID and TABLETS and INJECTION (2nd line)
FUROSEMIDE INJECTION (1st line), LIQUID and TABLETS (1st line)

2.2.3

Potassium-sparing diuretics and aldosterone antagonists

AMILORIDE LIQUID and TABLETS
SPIRONOLACTONE TABLETS
SPIRONOLACTONE LIQUID (adult patients)
SPIRONOLACTONE LIQUID (paediatrics)
EPLERENONE TABLETS

2.2.4

Potassium-sparing diuretics with other diuretics

CO-AMILOFRUSE TABLETS
CO-AMILOZIDE TABLETS

2.2.5

Osmotic diuretics

MANNITOL INFUSION 10% and 20%

2.2.8

Diuretics with potassium

2.3

Anti-arrythmic drugs

2.3.2

Drugs for arrythmias

ADENOSINE INJECTION
AMIODARONE INJECTION and TABLETS
FLECAINIDE INJECTION and TABLETS
LIDOCAINE 0.4% in GLUCOSE 5% INFUSION
Magnesium Sulfate Injection
DRONEDARONE 400mg TABLETS – secondary care initiation only / TA197 -Atrial fibrillation - dronedarone

2.4

Beta-adrenergic blocking drugs

ATENOLOL INJECTION, LIQUID and TABLETS
BISOPROLOL TABLETS
CARVEDIOL TABLETS
ESMOLOL INJECTION
LABETALOL INJECTION and TABLETS
METOPROLOL TABLETS
PROPRANOLOL CAPSULES and TABLETS
PROPRANOLOL 10mg/5ml SYRUP
METOPROLOL 5mg/5ml INJECTION
SOTALOL TABLETS

2.5

Hypertension and heart failure

2.5.1

Vasodilator antihypertensive drugs

HYDRALAZINE INJECTION and TABLETS

2.5.2

Centrally acting antihypertensive drugs

CLONIDINE INJECTION
MOXONIDINE TABLETS
METHYLDOPA TABLETS

2.5.3

Adrenergic neurone blocking drugs

2.5.4

Alpha-adrenergic neurone blocking drugs

DOXAZOSIN TABLETS
PHENTOLAMINE INJECTION

2.5.5

Drugs affecting the renin-angiotensin system

2.5.5.1

Angiotensin-converting enzyme inhibitors

ENALAPRIL TABLETS
LISINOPRIL TABLETS
PERINDOPRIL TABLETS
RAMIPRIL CAPSULES
CAPTOPRIL 25mg/5ml SOLUTION (paediatrics only)

2.5.5.2

Angiotensin-II receptor antagonists

CANDESARTAN TABLETS
IRBESARTAN TABLETS
LOSARTAN TABLETS
VALSARTAN TABLETS
SACUBITRIL/VALSARTAN (ENTRESTO) / TA 388 for treating symptomatic chronic heart failure with reduced ejection fraction

2.6

Nitrates, calcium-channel blockers and other antianginal drugs

2.6.1

Nitrates

GLYCERYL TRINITRATE 400microgram S/L SPRAY
ISOSORBIDE DINITRATE TABLETS AND INFUSION
ISOSORBIDE MONONITRATE and M/R TABLETS
GLYCERYL TRINITRATE 10mg in 24hrs PATCHES
GLYCERYL TRINITRATE 5mg in 24hrs PATCHES
GLYCERYL TRINITRATE 500microgram S/L TABLETS
ISOSORBIDE MONONITRATE TABLETS

2.6.2

Calcium channel blockers (note diltiazem, nifedipine and verapamil should be prescribed by brand due to differences in bioavailability)

AMLODIPINE TABLETS
DILTIAZEM M/R CAPSULES (Adizem-SR)
DILTIAZEM M/R CAPSULES (Adizem-XL)
DILTIAZEM M/R CAPSULES (Angitil SR)
DILTIAZEM M/R CAPSULES (Angitil XL)
DILTIAZEM M/R CAPSULES (Dilzem SR)
DILTIAZEM M/R CAPSULES (Dilzem XL)
DILTIAZEM M/R CAPSULES (Slozem)
DILTIAZEM M/R CAPSULES (Tildiem LA)
DILTIAZEM M/R CAPSULES (Viazem XL)
DILTIAZEM M/R TABLETS (Tildiem Retard)
DILTIAZEM 60mg M/R TABLETS
NIFEDIPINE MR TABLETS (Adalat Retard, Adipine MR, Nifedipress)
NIFEDIPINE SR TABLETS (Adalat LA, Adarif SR, Adipine XL)
NIFEDIPINE 10mg capsules (for maternity and Reynauds)
NIMODIPINE INFUSION and TABLETS
VERAPAMIL TABLETS, SOLUTION AND INJECTION
VERAPAMIL MR (Tillomed, Univer, Verapress MR)
FELODIPINE M/R TABLETS
LERCANIDIPINE TABLETS

2.6.3

Other antianginal drugs

NICORANDIL TABLETS
IVABRADINE TABLETS / TA267 Ivabradine for treating chronic heart failure
RANOLAZINE 375mg & 500mg TABLETS As adjunctive therapy in patients inadequately controlled or intolerant of 1st line antianginal drugs

2.6.4

Peripheral vasodilators and related drugs

NAFTIDROFURYL CAPSULES /

TA223 Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

CILOSTAZOL TABLETS (not recommended by NICE)

2.7

Sympathomimetics

ADRENALINE 1 in 1000 (5mg/5ml) INJECTION
DOBUTAMINE INJECTION
DOPAMINE INJECTION
DOPEXAMINE INJECTION
ISOPRENALINE INJECTION 0.2MG/ML - unlicensed

2.7.2

Vasoconstrictor sympathomimetics

EPHEDRINE INJECTION
METARAMINOL INJECTION
NORADRENALINE INJECTION
PHENYLEPHRINE INJECTION

2.7.3

Cardiopulmonary resuscitation

ADRENALINE 1 in 10.000 (100microgram/ml) INJECTION

2.7.4

/ Bleeding Disorders
IDARUCIZUMAB (PRAXBIND)
ADRENALINE 1:100000 (UNLICENSED) for management of bleeding post-frenulectomy

2.8

Anticoagulants and protamine

2.8.1

Parenteral anticoagulants

TINZAPARIN INJECTION

ENOXAPARIN INJECTION (for treatment of PE/DVT in patients with Renal Impairment, NPSA/2010/RRR014)
EPOPROSTENOL INJECTION
HEPARIN SODIUM 1000units/ml INJECTION
HEPARIN SODIUM 200units/2ml INJECTION
HEPARIN SODIUM 5000units/ml 5ml VIAL INJECTION
HEPARIN SODIUM 5000units/0.2ml INJECTION
HEPARIN SODIUM 1000units/ml 5ml VIAL INJECTION
HEPARIN SODIUM 500units in 0.9% SODIUM CHLORIDE INFUSION
HEPARIN SODIUM 50units/5ml INJECTION
DALTEPARIN INJECTION for Christie Patients (Licensed for treatment & prophylaxis of VTE in patients with solid tumours)
FONDAPARINUX 2.5mg/0.5ml INJECTION max 5 days for ACS. Under directions of cardiologists for extended use.
DANAPAROID INJECTION
LEPIRUDIN INJECTION

2.8.2

Oral anticoagulants

APIXABAN

TA245 Venous thromboembolism (hip and knee surgery)

TA275 Stroke and systemic embolism (prevention, non- valvular atrial fibrillation)
TA341 Treatment and secondary prevention of DVT and/or PE
WARFARIN TABLETS
ACENOCOUMAROL TABLETS
PHENINDIONE TABLETS
DABIGATRAN / TA157 Venous Thromboembolism – dabigatran
TA249 Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation
TA327 – treatment and secondary prevention of DVT and PE
RIVAROXABAN / TA170 Rivaroxaban for the prevention of venous thromboembolism
TA256 Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation
TA261 Venous thromboembolism (treatment and long term prevention)
TA287 Pulmonary embolism and recurrent venous thromboembolism
TA 335 Acute management of ACS
EDOXABAN / TA 355, for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation

2.8.3

Protamine sulphate

PROTAMINE SULPHATE INJECTION

2.9

Antiplatelet drugs

ASPIRIN 75mg DISPERSIBLE TABLETS
CLOPIDOGREL 75mg TABLETS / TA210 Vascular disease Clopidogrel and dipyridamole
DIPYRIDAMOLE 200mg M/R CAPSULES / TA 210 Vascular disease Clopidogrel and dipyridamole
DIPYRIDAMOLE 100mg/5ml SUSPENSION (unlicensed special)
TIROFIBAN 50mcg/ml 250ml Intravenous Infusion
PRASUGREL 10mg TABLETS / NICE TA182 Acute coronary syndrome – prasugrel
TA317 – review of TA182
TICAGRELOR 90mg and 60mg TABLETS / NICE TA 236 – Acute Coronary Syndrome – Ticagrelor
TA 420

2.10

Stable angina, acute coronary syndromes and fibrinolysis

2.10.2

Fibrinolytic drugs

STREPTOKINASE INJECTION
TENECTEPLASE INJECTION
UROKINASE INJECTION / Aug 2017 – also approved for localised pleural effusions
ALTEPLASE INJECTION (Thrombolysis trained consultants only) / Yes (except for stroke) / TA264 Stroke (acute, ischaemic) - alteplase

2.11

Antifibrinolytic drugs and haemostatics

FERRIC SUBSULPHATE (MONSEL’S) SOLUTION
TRANEXAMIC INJECTION, LIQUID and TABLETS

2.12

Lipid regulating drugs

BEZAFIBRATE 200mg TABLETS
BEZAFIBRATE 400mg M/R TABLETS
COLESTYRAMINE 4g SACHETS
COLESTYRAMINE LIGHT 4g SACHETS
PRAVASTATIN TABLETS / TA94 - Cardiovascular disease - statins
SIMVASTATIN TABLETS / TA94 - Cardiovascular disease - statins
ATORVASTATIN 40mg TABLETS / TA94 - Cardiovascular disease - statins
ATORVASTATIN 80mg TABLETS / TA94 - Cardiovascular disease - statins
FENOFIBRATE CAPSULES and TABLETS
EZETIMIBE / TA385 Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia

2.13

Local sclerosants

SODIUM TETRADECYL SULPHATE 3% INJECTION

2.14

Drugs affecting the ductus arteriosus

IBUPROFEN INJECTION
3 /

Respiratory system

PBR

Relevant NICE TA

3.1

Bronchodilators

3.1.1

Adrenoceptor agonists

3.1.1.1

Selective beta2 agonists

SALBUTAMOL 100microgram INHALER CFC-free
SALBUTAMOL 2.5mg/2.5ml NEBULISER SOLUTION
SALBUTAMOL 5mg/2.5ml NEBULISER SOLUTION
SALBUTAMOL 200microgram ACCUHALER
SALBUTAMOL 2mg/5ml SF LIQUID
SALBUTAMOL INJECTION
SALMETEROL 25microgram INHALER
SALMETEROL 50microgram ACCUHALER
TERBUTALINE 500microgram TURBOHALER
TERBUTALINE 5mg/2ml NEBULISER SOLUTION
SALBUTAMOL 100microgram EASI-BREATHE INHALER
TERBUTALINE INJECTION

3.1.2

Antimuscarinic bronchodilators

IPRATROPIUM 20microgram INHALER CFC-free
IPRATROPIUM 250microgram/1ml NEBULISER SOLUTION
IPRATROPIUM 500microgram/2ml NEBULISER SOLUTION
TIOTROPIUM 18microgram capsules (for use with HANDIHALER)
ACLIDINIUM 400micrograms INHALER
UMECLIDINIUM 55 microgram inhaler

3.1.3

Theophylline

AMINOPHYLLINE INJECTION and M/R TABLETS
THEOPHYLLINE M/R CAPSULES (Slo-phyllin)
THEOPHYLLINE M/R TABLETS (Uniphyllin continus)
3.1.4 / Compound Bronchodilator Preparations
ANORO ELLIPTA
DUAKLIR GENUAIR
ULTIBRO BREEZHALER

3.1.5

Peak flow meters, inhaler devices and nebulisers

AEROCHAMBER DEVICES
HALERAIDS
PEAK FLOW METERS
VOLUMATICS

3.2

/ Corticosteroids
BECLOMETASONE 100microgram INHALER (Clenil)
BECLOMETASONE 100microgram AUTOHALER (Qvar)
BECLOMETASONE 100microgram INHALER (Qvar)
BECLOMETASONE 200microgram INHALER (Clenil)
BECLOMETASONE 250microgram INHALER (Clenil)
BECLOMETASONE 50microgram INHALER (Clenil)
BUDESONIDE 100microgram TURBOHALER (Pulmicort)
BUDESONIDE 1mg/2ml RESPULES
BUDESONIDE 200microgram TURBOHALER (Pulmicort)
BUDESONIDE 400microgram TURBOHALER (Pulmicort)
BUDESONIDE 500microgram/2ml RESPULES
FLUTICASONE 250microgram EVOHALER
FLUTICASONE 100microgram ACCUHALER
FLUTICASONE 125microgram INHALER
FLUTICASONE 250microgram ACCUHALER
FLUTICASONE 500microgram ACCUHALER
FLUTICASONE 50microgram ACCUHALER
FLUTICASONE 50microgram INHALER
FOSTAIR 100/6 INHALER
FLUTIFORM 50/5 125/5 250/10 INHALER
SERETIDE 100 ACCUHALER
SERETIDE 125 EVOHALER
SERETIDE 250 ACCUHALER
SERETIDE 250 EVOHALER (Use Accuhaler unless compliance/technique issue)
SERETIDE 50 EVOHALER
SERETIDE 500 ACCUHALER
AERIVO SPIROMAX inhaler (fluticasone and salmeterol)
SYMBICORT 100/6 TURBOHALER
SYMBICORT 200/6 TURBOHALER (if 2p bd use 400/12 1p bd)
SYMBICORT 400/12 TURBOHALER
DUORESP SPIROMAX 160/4.5 / Approved at APC 11.11.14
DUORESP SPIROMAX 320/9 / Approved at APC 11.11.14
RELVAR ELLIPTA / Approved at APC 14.11.15
TRIMBOW / Approved APG 7.11.17
TRELEGY / Approved MMG Feb 2018

3.3

Cromoglicate and related therapy, leukotriene receptor antagonists and phosphodiesterase type-4 inhibitors

3.3.1

Cromoglicate and related therapy

3.3.2

Leukotriene receptor antagonists

MONTELUKAST SACHETS and TABLETS
ZAFIRLUKAST TABLETS (2nd line)

3.4

Antihistamines, hyposensitisation and allergic emergencies

3.4.1

Antihistamines

ALIMEMAZINE LIQUID 30mg/5ml
CETIRIZINE LIQUID and TABLETS
CHLORPHENAMINE INJECTION, LIQUID and TABLETS
HYDROXYZINE LIQUID and TABLETS
LORATADINE LIQUID AND TABLETS
PROMETHAZINE INJECTION, LIQUID and TABLETS
3.4.2 / Allergen Immunotherapy
OMALIZUMAB / TA339 previously treated chronic spontaneous urticaria

3.4.3

Allergic emergencies

ADRENALINE 1 in 1000 (1mg/1ml) INJECTION
ADRENALINE 150micrograms/0.3ml SYRINGE
ADRENALINE 300micrograsm/0.3ml SYRINGE
JEXT TRAINER PEN
C1-INHIBITOR TIM3 500units (MM1 form required retrospectively as URGENT CARE) / Yes

3.5

Respiratory stimulants and pulmonary surfactants

3.5.1

Respiratory stimulants

CAFFEINE CITRATE INJECTION and LIQUID
DOXAPRAM 100mg/5ml INJECTION
DOXAPRAM 1g in GLUCOSE 5% INFUSION

3.5.2

Pulmonary surfactants

PORACTANT ALFA SUSPENSION ( EMERGENCY CARE – MM1 FORM NOT REQUIRED) / Yes

3.7

Mucolytics

CARBOCISTEINE 375mg CAPSULES
CARBOCISTEINE 250mg/5ml LIQUID
SODIUM CHLORIDE 3% NEBULISER SOLUTION
SODIUM CHLORIDE 7% NEBULISER SOLUTION

3.8

Aromatic inhalations

3.9

Cough preparations

3.9.1

Cough suppressants

CODEINE 15mg/5ml LINCTUS
PHOLCODEINE LINCTUS

3.9.2

Demulcent and expectorant cough preparations

SIMPLE LINCTUS SF

3.10

Systemic nasal decongestants

OTHER / ROFLUMILAST / TA 461
4 /

Central nervous system

4.1

Hypnotics and anxiolytics

4.1.1

Hypnotics

MELATONIN 2mg M/R TABLETS
NITRAZEPAM 5mg TABLETS
TEMAZEPAM LIQUID and TABLETS (n.b controlled drug)
ZOPICLONE TABLETS
MELATONIN 2mg CAPSULES (n.b unlicensed)
MELATONIN 3mg CAPSULES (n.b. unlicensed)

4.1.2

Anxiolytics

CHLODIAZEPOXIDE CAPSULES
DIAZEPAM LIQUID and TABLETS
LORAZEPAM INJECTION and TABLETS

4.2

Drugs used in psychoses and related disorders

4.2.1

Antipsychotic drugs

CHLORPROMAZINE 50mg/2ml INJECTION
HALOPERIDOL CAPSULES, INJECTION, LIQUID and TABLETS
OLANZAPINE INJECTION
PROMAZINE LIQUID and TABLETS
LEVOMEPROMAZINE INJECTION and TABLETS
OLANZAPINE ORODISPERSIBLE TABLETS and TABLETS
QUETIAPINE LIQUID, M/R TABLETS and TABLETS
RISPERIDONE LIQUID, ORODISPERSIBLE TABLETS and TABLETS

4.2.2

Antipsychotic depot injections

FLUPENTIXOL DECANOATE INJECTION
HALOPERIDOL DECANOATE INJECTION
PIPOTIAZINE INJECTION
RISPERIDONE INJECTION
ZUCLOPENTIXOL DECANOATEINJECTION

4.2.3

Antimanic drugs

LITHIUM CARBONATE M/R TABLETS (Priadel)

4.3

Antidepressant drugs

4.3.1

Tricyclic and related antidepressant drugs

AMITRIPTYLINE LIQUID and TABLETS
CLOMIPRAMINE CAPSULES
IMIPRAMINE TABLETS
LOFEPRAMINE LIQUID and TABLETS
NORTRIPTYLINE TABLETS
TRAZADONE CAPSULES and LIQUID
TRIMIPRAMINE CAPSULES and TABLETS
DOSULEPIN CAPSULES and TABLETS

4.3.2

Monoamine-oxidase inhibitors

4.3.3

Selective serotonin re-uptake inhibitors

CITALOPRAM ORAL DROPS and TABLETS n.b. 4 drops of liquid (8mg) is therapeutically equivalent to 10mg tablet
FLUOXETINE CAPSULES and LIQUID
PAROXETINE TABLETS and LIQUID
SERTRALINE TABLETS
ESCITALOPRAM TABLETS

4.3.4

Other antidepressant drugs

MIRTAZAPINE ORODISPERSIBLE TABLETS and plain TABLETS
VENLAFAXINE M/R CAPSULES and TABLETS
DULOXETINE CAPSULES

4.4

CNS stimulants and drugs used for attention deficit hyperactivity disorder

4.5

Drugs used in the treatment of obesity

4.5.1

Anti-obesity drugs acting on the gastro-intestinal tract

ORLISTAT CAPSULES

4.5.2

Centrally acting appetite suppressants

4.6

Drugs used in nausea and vertigo

BETAHISTINE TABLETS
CINNARIZINE TABLETS
CYCLIZINE INJECTION and TABLETS
DOMPERIDONE LIQUID, SUPPOSITORIES and TABLETS
HYOSCINE HYDROBROMIDE TABLETS 300microgram
HYOSCINE PATCHES
METOCLOPRAMIDE INJECTION, LIQUID AND TABLETS
ONDANSETRON INJECTION, LIQUID and TABLETS
PROCHLORPERAZINE INJECTION, LIQUID and TABLETS
APREPITANT CAPSULES – following moderately and highly emetogenic chemotherapy
NETUPITANT/PALONOSETRON 300mg/0.5mg – prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based chemotherapy and moderately emetogenic cancer chemotherapy
GRANISETRON

4.7

Analgesia

4.7.1

Non-opioid analgesics and compound analgesic preparations

ASPIRIN DISPERSIBLE TABLETS, SUPPOSITORIES and TABLETS
CO-CODAMOL 8/500 EFFERVESCENT TABLETS
CO-CODAMOL 8/500 TABLETS
CO-CODAMOL 30/500 TABLETS
PARACETAMOL 1000mg/100ml INFUSION (nb Max dose 15mg/kg if patient weighs <50kg)
PARACETAMOL 60mg SUPPOSITORIES 60mg, 120mg, 240mg, 1g)
PARACETAMOL 120mg/5ml SF SUSPENSION
PARACETAMOL 250mg/5ml SUSPENSION
PARACETAMOL 500mg TABLETS
CO-CODAMOL 30/500 EFFERVESCENT TABLETS (note high sodium content)
NEFOPAM TABLETS
PARACETAMOL 500mg/5ml SUSPENSION

4.7.2

Opioid analgesics

CODEINE PHOSPHATE INJECTION, LIQUID and TABLETS
DIAMORPHINE INJECTION
DIHYDROCODEINE LIQUID and TABLETS
FENTANYL MATRIX PATCHES
METHADONE 1mg/ml INJECTION
MORPHINE SULPHATE 10mg TABLETS (Sevredol)
MORPHINE SULPHATE LIQUID
MORPHINE SULPHATE M/R CAPSULES (Zomorph)
MORPHINE SULPHATE INJECTION
MORPHINE SULPHATE 0.1% infusion
MORPHINE SULPHATE 5mg M/R TABLETS (MST continus)
OXYCODONE HYDROCHLORIDE M/R TABLETS (Oxycontin) (Sustained Release)
OXYCODONE HYDROCHLORIDE 5mg/5ml. 50mg/5ml SF LIQUID and CAPSULES 5mg, 10mg (Oxynorm) (Immediate Release) and INJECTION
TRAMADOL CAPSULES, INJECTION and M/R TABLETS
BUPRENORPHINE PATCHES
BUPRENORPHINE 200microgram SUBLINGUAL TABLETS
BUPRENORPHINE 300microgram/ml INJECTION
PETHIDINE INJECTION
FENTANYL SUBLINGUAL AND BUCCAL TABLETS and NASAL SPRAY – on advice of palliative care
MEPTAZINOL INJECTION
TRAMADOL 50mg SOLUBLE TABLETS
TRAMADOL M/R 100mg; 200mg

TARGINACT TABLETS (for post operative pain on orthopaedic wards ONLY)